Ftse Mib
33.541,98
-0,49%
DAX
18.155,24
-0,04%
S&P 500
5.477,90
0,16%
NASDAQ
17.805,16
0,49%
Bitcoin
61.039,99
0,37%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Biora Therapeutics Inc (BIOR) Biora Therapeutics Inc (BIOR) Notizie

Biora Therapeutics Inc

BIOR
0,654
-0,0217 (-3,21%)
27 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/6/202422:30EDGAR2Form 8-K - Current report
11/6/202414:00GLOBEBiora Therapeutics Announces Presentation on the BioJet™..
07/6/202413:31EDGAR2Form 8-K - Current report
06/6/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
20/5/202422:08EDGAR2Form S-3 - Registration statement under Securities Act of..
20/5/202422:06EDGAR2Form S-3 - Registration statement under Securities Act of..
20/5/202414:00GLOBEBiora Therapeutics Presents Clinical Data on Device Function..
15/5/202422:05GLOBEBiora Therapeutics Provides Corporate Update..
07/5/202414:00GLOBEBiora Therapeutics to Report First Quarter 2024 Financial..
06/5/202414:00GLOBEBiora Therapeutics to Present Clinical Data on Device..
30/4/202414:00GLOBEBiora Therapeutics Announces Completion of..
08/4/202414:00GLOBEBiora Therapeutics Announces New Patent Covering its BioJet™..
04/4/202414:00GLOBEBiora Therapeutics Achieves Positive Interim Results for..
03/4/202422:05GLOBEBiora Therapeutics Announces Closing of $6 Million..
01/4/202414:00GLOBEBiora Therapeutics Announces $6 Million Registered Direct..
26/3/202421:05GLOBEBiora Therapeutics Provides Corporate Update and Reports..
26/3/202412:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
18/3/202413:00GLOBEBiora Therapeutics to Report Fourth Quarter and Full Year..
11/3/202413:11EDGAR2Form 8-K - Current report
11/3/202413:00GLOBEBiora Therapeutics Further Reduces Net Debt and Monetizes..
26/2/202414:00GLOBEBiora Therapeutics Announces Successful Completion of..
15/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202420:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202414:00GLOBEBiora Therapeutics Announces Participation in Canaccord..
22/1/202414:00GLOBEBiora Therapeutics Announces Participation in Fireside Chat..
16/1/202423:20EDGAR2Form 8-K - Current report
16/1/202414:00GLOBEBiora Therapeutics Provides Outlook for 2024
08/1/202414:00GLOBEBiora Therapeutics Announces Initiation of Phase 1 Clinical..
02/1/202414:00GLOBEBiora Therapeutics Progresses Research Collaboration for the..
22/12/202323:19EDGAR2Form S-3 - Registration statement under Securities Act of..
20/12/202322:35EDGAR2Form SC 13D/A - General statement of acquisition of..
19/12/202314:00GLOBEBiora Therapeutics Announces New Patent for its NaviCap™..
18/12/202314:06EDGAR2Form 8-K - Current report
18/12/202314:00GLOBEBiora Therapeutics Accelerates Debt Reduction and Raises..
15/12/202323:25EDGAR2Form 8-K - Current report
11/12/202314:00GLOBEBiora Therapeutics Announces New Research Collaboration for..
01/12/202312:06EDGAR2Form 8-K - Current report
01/12/202300:53DJNBiora Therapeutics Shares Rise 64% After FDA Clears..
30/11/202323:29DJNBiora Therapeutics Application for Ulcerative Colitis..
30/11/202322:48GLOBEBiora Therapeutics Announces FDA Clearance of IND..
13/11/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:05GLOBEBiora Therapeutics Provides Corporate Update and Reports ..
06/11/202314:00GLOBEBiora Therapeutics to Report Third Quarter 2023 Financial..
30/10/202321:05GLOBEBiora Therapeutics Submits Updated IND Application for..
23/10/202323:30GLOBEBiora Therapeutics to Submit Updated IND Application for..
Apertura: 0,66 Min: 0,6094 Max: 0,67428
Chiusura: 0,6757

La tua Cronologia

NASDAQ
BIOR
Biora Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network